Alexandru Schiopu
21 – 30 of 78
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Invariant natural killer T cells and incidence of first-time coronary events : a nested case-control study
- Contribution to journal › Article
-
Mark
Therapeutic S100A8/A9 blockade inhibits myocardial and systemic inflammation and mitigates sepsis-induced myocardial dysfunction
- Contribution to journal › Article
-
Mark
Long-term Safety of Revascularization Deferral Based on Instantaneous Wave-Free Ratio or Fractional Flow Reserve
- Contribution to journal › Article
-
Mark
Organizational and patient-level predictors for attaining key risk factor targets in cardiac rehabilitation after myocardial infarction : The Perfect-CR study
- Contribution to journal › Article
- 2022
-
Mark
Short‐Term Blockade of Pro‐Inflammatory Alarmin S100A9 Favorably Modulates Left Ventricle Proteome and Related Signaling Pathways Involved in Post‐Myocardial Infarction Recovery
- Contribution to journal › Article
-
Mark
Safety of early hospital discharge following admission with ST-elevation myocardial infarction treated with percutaneous coronary intervention : A nationwide cohort study
- Contribution to journal › Article
-
Mark
Effect of a Lifestyle-Focused Web-Based Application on Risk Factor Management in Patients Who Have Had a Myocardial Infarction : Randomized Controlled Trial
- Contribution to journal › Article
-
Mark
S100A9 induces reactive oxygen species-dependent formation of neutrophil extracellular traps in abdominal sepsis
- Contribution to journal › Article
- 2021
-
Mark
Studying the innate immune response to myocardial infarction in a highly efficient experimental animal model
- Contribution to journal › Article
-
Mark
Targeting s100a9 reduces neutrophil recruitment, inflammation and lung damage in abdominal sepsis
- Contribution to journal › Article
